As shown in Figure 3(b), the mRNA expression of TUBA1C was high in adrenocortical carcinoma (ACC), uterine carcinosarcoma (UCS), testicular germ cell tumour (TGCT), ovarian serous cystadenocarcinoma (OV), brain low-grade glioma (LGG), and acute myeloid leukaemia (LAML). This evidence concerns the gene TUBA1C and ovarian serous cystadenocarcinoma.